Filing Details
- Accession Number:
- 0000950170-24-075625
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-20 16:30:06
- Reporting Period:
- 2024-06-17
- Accepted Time:
- 2024-06-20 16:30:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1651311 | Merus N.v. | MRUS | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1790314 | B. Peter Silverman | C/O Merus N.v. Uppsalalaan 17 Utrecht P7 3584 CT | Coo & Gc | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2024-06-17 | 8,423 | $25.90 | 8,423 | No | 4 | M | Direct | |
| Common Shares | Acquisiton | 2024-06-17 | 41,577 | $25.90 | 50,000 | No | 4 | M | Direct | |
| Common Shares | Acquisiton | 2024-06-17 | 2,747 | $17.94 | 52,747 | No | 4 | M | Direct | |
| Common Shares | Acquisiton | 2024-06-17 | 9,253 | $17.94 | 62,000 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2024-06-17 | 62,000 | $56.52 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Share Option (right to buy) | Disposition | 2024-06-17 | 8,423 | $0.00 | 8,423 | $25.90 |
| Common Shares | Share Option (right to buy) | Disposition | 2024-06-17 | 41,577 | $0.00 | 41,577 | $25.90 |
| Common Shares | Share Option (right to buy) | Disposition | 2024-06-17 | 2,747 | $0.00 | 2,747 | $17.94 |
| Common Shares | Share Option (right to buy) | Disposition | 2024-06-17 | 9,253 | $0.00 | 9,253 | $17.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2027-02-15 | No | 4 | M | Direct | |
| 0 | 2027-02-15 | No | 4 | M | Direct | |
| 2,547 | 2028-02-21 | No | 4 | M | Direct | |
| 7,453 | 2028-02-21 | No | 4 | M | Direct |
Footnotes
- These transactions were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 15, 2024.
- The option is fully vested and exercisable.
Billionaire Hedge Funds
